Grünenthal USA Inc.
Partner in Pain Management
Grünenthal USA is a subsidiary of Grünenthal GmbH, an independent, family-owned pharmaceutical company specializing in pain management.
Grünenthal USA partners with other leading pharmaceutical companies to deliver innovative products to patients living with pain.
Grünenthal USA, Inc.
360 Mount Kemble Avenue
Morristown, NJ 07960
Strategic Agreement with Patheon
Grünenthal selected Patheon to develop drugs using INTAC® abuse deterrent formulations technology
Patheon, the leading global provider of pharmaceutical development and manufacturing services announced it has signed a strategic agreement with Grünenthal to serve as its preferred development partner for its products made using Grünenthal’s innovative abuse deterrent formulation technology INTAC®.
Patheon was selected to assist with the development of advanced INTAC® based products including single-entity and fixed-dose combination solid oral dosage forms with immediate and modified release properties. INTAC® is Grünenthal’s proprietary technology designed to reduce the potential for abuse of controlled substances.